SCHEMBL7754154

SCHEMBL7754154

COC(=O)CN1CN(c2ccccc2)C2(CCN(CCCc3ccccc3)CC2)C1=O

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.67
CYP3A4 P08684 2/20 0.67
CYP2D6 P10635 2/20 0.67
KMT2A Q03164 2/20 0.67
CYP2C9 P11712 1/20 0.67
OPRL1 P41146 2/20 0.64
OPRM1 P35372 1/20 0.60
OPRK1 P41145 1/20 0.60
BDKRB2 P30411 1/20 0.57
NPC1L1 Q9UHC9 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
MAPT P10636 1/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
CYP2C19 P33261 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7757882 0.94 MEN1 (0.69) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7758870 0.87 MEN1 (0.66) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7759204 0.87 MEN1 (0.65) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7754115 0.85 OPRL1 (0.60) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7757108 0.84 OPRL1 (0.64) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7757095 0.82 OPRL1 (0.83) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL20187031 0.82 OPRL1 (0.67) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7992816 0.82 OPRL1 (0.66) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7759170 0.82 MEN1 (0.77) MEN1CYP3A4CYP2D6KMT2ACYP2C9
SCHEMBL7995842 0.82 CYP2D6 (0.80) MEN1CYP3A4CYP2D6KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277991-B1 FOR TREATMENT OF MIGRAINE, NON-INSULIN DEPENDENT DIABETES MELLITUS, SEPSIS, INFLAMMATION, INCONTINENCE, VASOMOTOR DISTURBANCES SUCH AS HOT FLUSHES OR HOT FLASHES NOVO NORDISK A/S (DK) 2001-08-21 US claimed
EP-1080091-A1 NOVEL 1,3,8-TRIAZASPIRO[4.5]DECANONES WITH HIGH AFFINITY FOR OPIOID RECEPTOR SUBTYPES Novo Nordisk A/S (DK) 2001-03-07 EP claimed
WO-1999059997-A1 NOVEL 1,3,8-TRIAZASPIRO[4.5]DECANONES WITH HIGH AFFINITY FOR OPIOID RECEPTOR SUBTYPES NOVO NORDISK A/S (DK) 1999-11-25 WO claimed
US-6277991-B1 FOR TREATMENT OF MIGRAINE, NON-INSULIN DEPENDENT DIABETES MELLITUS, SEPSIS, INFLAMMATION, INCONTINENCE, VASOMOTOR DISTURBANCES SUCH AS HOT FLUSHES OR HOT FLASHES NOVO NORDISK A/S (DK) 2001-08-21 US disclosed